Gabriel Rabinovich científico argentino
Rabinovich, Gabriel
Rabinovich, Gabriel Adrián
VIAF ID: 46569474 (Personal)
Permalink: http://viaf.org/viaf/46569474
Preferred Forms
- 100 0 _ ‡a Gabriel Rabinovich ‡c científico argentino
- 100 1 _ ‡a Rabinovich, Gabriel
- 100 1 _ ‡a Rabinovich, Gabriel
-
- 100 1 _ ‡a Rabinovich, Gabriel Adrián
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Characterization and functionality of proliferative human Sertoli cells | |
Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities | |
Classification of current anticancer immunotherapies | |
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death | |
Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments | |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma | |
Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity? | |
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings | |
Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer | |
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment | |
Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applications. | |
Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity | |
Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression. | |
Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed | |
Functions of cell surface galectin-glycoprotein lattices | |
Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities | |
Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss. | |
Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression | |
Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction | |
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration | |
Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF | |
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 regulatory T cells | |
The galectin-1-glycan axis controls sperm fertilizing capacity by regulating sperm motility and membrane hyperpolarization. | |
Galectin-1 is essential for efficient liver regeneration following hepatectomy | |
Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin FKBP52 | |
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. | |
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. | |
Galectin-8 Ameliorates Murine Autoimmune Ocular Pathology and Promotes a Regulatory T Cell Response | |
Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGFβ signaling | |
A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders | |
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? | |
Galectins as modulators of tumour progression | |
Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis | |
Galectins in hematological malignancies | |
Galectins: structure, function and therapeutic potential | |
Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet | |
Glycobiology of the immune response | |
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors | |
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. | |
[How do protein-glycan interactions regulate T-cell physiology?]. | |
Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies. | |
The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation | |
Inflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1. | |
Inmunopatología molecular: nuevas fronteras de la medicina, 2004: | |
IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity | |
Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarization | |
Lack of TNFR p55 Results in Heightened Expression of IFN-γ and IL-17 during the Development of Reactive Arthritis | |
Ligand-mediated Galectin-1 endocytosis prevents intraneural H2O2 production promoting F-actin dynamics reactivation and axonal re-growth | |
Linking the structure and thermal stability of beta-galactoside-binding protein galectin-1 to ligand binding and dimerization equilibria | |
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference | |
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model | |
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses | |
Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. | |
Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8. | |
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. | |
Multiple functional targets of the immunoregulatory activity of galectin-1: Control of immune cell trafficking, dendritic cell physiology, and T-cell fate. | |
Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. | |
Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. | |
Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling | |
Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells. | |
A pivotal role for galectin-1 in fetomaternal tolerance | |
Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure | |
Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery. | |
Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase | |
Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues | |
Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1 | |
Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape. | |
Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment | |
Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. | |
Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. | |
Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway | |
Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid | |
Study of galectins in tumor immunity: strategies and methods | |
Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment | |
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | |
Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis | |
Thwarting galectin-induced immunosuppression in breast cancer | |
Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. | |
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. | |
Translating the 'Sugar Code' into Immune and Vascular Signaling Programs | |
Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms. | |
TSLP1: a new piece in the puzzle of tumor-associated Th2-type inflammation | |
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer | |
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation | |
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. | |
Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology. | |
Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation. | |
When galectins recognize glycans: from biochemistry to physiology and back again |